NAC and DTT reduce TGF-β activity in monocytes
Author Information
Author(s): Frank J Lichtenberger III, Christine R Montague, Melissa Hunter, Gwyn Frambach, Clay B Marsh
Primary Institution: The Ohio State University
Hypothesis
Do thiol compounds like NAC and DTT affect the activation of TGF-β by monocytes?
Conclusion
NAC and DTT reduce the biological activity of TGF-β after activation, suggesting a potential therapeutic approach for pulmonary fibrosis.
Supporting Evidence
- NAC and DTT reduced the activity of TGF-β produced by human monocytes.
- The study showed that NAC and DTT did not suppress TGF-β mRNA transcription.
- Diamide restored biological activity to NAC or DTT-treated TGF-β.
Takeaway
This study found that two compounds, NAC and DTT, can change a protein called TGF-β so it doesn't work as well, which might help people with lung problems.
Methodology
The study involved treating human monocytes with NAC and DTT and measuring TGF-β activity using a luciferase reporter assay.
Participant Demographics
Human monocytes obtained from healthy volunteers.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website